A detailed history of Lri Investments, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Lri Investments, LLC holds 6,277 shares of NVO stock, worth $895,978. This represents 0.11% of its overall portfolio holdings.

Number of Shares
6,277
Holding current value
$895,978
% of portfolio
0.11%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 21, 2024

SELL
$102.11 - $135.92 $632,367 - $841,752
-6,193 Reduced 98.66%
84 $10.8 Million
Q1 2024

May 14, 2024

BUY
$102.11 - $135.92 $640,944 - $853,169
6,277 New
6,277 $831 Million

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $322B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Lri Investments, LLC Portfolio

Follow Lri Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lri Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lri Investments, LLC with notifications on news.